The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts
- PMID: 7683208
- DOI: 10.1016/0925-4439(93)90110-m
The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts
Abstract
The importance of methyl-thioIMP (Me-tIMP) formation for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity was studied in Molt F4 cells. Cytotoxicity of Me-MPR is caused by Me-tIMP formation with concomitant inhibition of purine de novo synthesis. Inhibition of purine de novo synthesis resulted in decreased purine nucleotide levels and enhanced 5-phosphoribosyl-1-pyrophosphate (PRPP) levels, with concurrent increased pyrimidine nucleotide levels. The Me-tIMP concentration increased proportionally with the concentration of Me-MPR. High Me-tIMP concentration also caused inhibition of PRPP synthesis. Maximal accumulation of PRPP thus occurred at low Me-MPR concentrations. As little as 0.2 microM Me-MPR resulted already after 2 h in maximal inhibition of formation of adenine and guanine nucleotides, caused by inhibition of purine de novo synthesis by Me-tIMP. Under these circumstances increased intracellular PRPP concentrations could be demonstrated, resulting in increased levels of pyrimidine nucleotides. So, in Molt F4 cells, formation of Me-tIMP from Me-MPR results in cytotoxicity by inhibition of purine de novo synthesis.
Similar articles
-
Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):163-8. doi: 10.1042/bj3040163. Biochem J. 1994. PMID: 7998928 Free PMC article.
-
Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts.Biochem Pharmacol. 1993 Aug 3;46(3):547-50. doi: 10.1016/0006-2952(93)90534-4. Biochem Pharmacol. 1993. PMID: 8347177
-
6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts.Biochem Pharmacol. 1993 Apr 6;45(7):1455-63. doi: 10.1016/0006-2952(93)90045-x. Biochem Pharmacol. 1993. PMID: 7682415
-
[PRPP synthetase superactivity].Nihon Rinsho. 1996 Dec;54(12):3309-14. Nihon Rinsho. 1996. PMID: 8976111 Review. Japanese.
-
Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase.Adv Enzyme Regul. 1989;28:167-82. doi: 10.1016/0065-2571(89)90070-8. Adv Enzyme Regul. 1989. PMID: 2560324 Review.
Cited by
-
Analytical and Sample Preparation Protocol for Therapeutic Drug Monitoring of 12 Thiopurine Metabolites Related to Clinical Treatment of Inflammatory Bowel Disease.Molecules. 2018 Jul 17;23(7):1744. doi: 10.3390/molecules23071744. Molecules. 2018. PMID: 30018218 Free PMC article.
-
Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.Cancer Chemother Pharmacol. 1995;35(3):191-9. doi: 10.1007/BF00686547. Cancer Chemother Pharmacol. 1995. PMID: 7805176
-
Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):163-8. doi: 10.1042/bj3040163. Biochem J. 1994. PMID: 7998928 Free PMC article.
-
Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies.Viruses. 2021 Dec 14;13(12):2508. doi: 10.3390/v13122508. Viruses. 2021. PMID: 34960780 Free PMC article.
-
Pharmacogenetics in inflammatory bowel disease.World J Gastroenterol. 2006 Jun 21;12(23):3657-67. doi: 10.3748/wjg.v12.i23.3657. World J Gastroenterol. 2006. PMID: 16773681 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous